Advertisement
The leading life science news channel in the Nordic region.
Business article - March 20, 2024
“The goal is for an organization with at least 500 employees to set up operations here. We already have the infrastructure needed to make us attractive to larger companies,” says Peter Juneblad, Business Director at Umeå Municipality. Umeå municipality’s Business Development Office has been specifically tasked with expanding the region’s life science industry, with a […]
Business Award - March 19, 2024
BioArctic’s founder, Professor Lars Lannfelt, was awarded the European Grand Prix for his research on Alzheimer’s disease at the anniversary gala for La Fondation Recherche Alzheimer in Paris on March 18. Professor Lannfelt received the award for his groundbreaking research, which has played a significant role in the scientific progress in the field over decades, […]
Business article - March 19, 2024
Read about seven trends that are shaping the life science sector right now, including concrete examples from Gothenburg. Experts at Business Region Göteborg have summarized seven particularly hot areas where they see advances that have the potential to fundamentally change healthcare, and where Gothenburg has several strengths. Trend 1: Increasingly important to control wounds and […]
In a new job - March 19, 2024
Lif Service AB (Lif) board has agreed with Johan Färnstrand to go their separate ways and that he will end his role as CEO. The fact that Lif’s board and Johan have now agreed that Johan will leave his position as CEO is due to different views on the continued governance and management of Lif, […]
Acquisition - March 19, 2024
AstraZeneca has entered into a definitive agreement to acquire Canadian Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). Under the terms of the definitive agreement, AstraZeneca, through a subsidiary, will acquire all of Fusion’s outstanding shares pursuant to a plan of arrangement for a price of USD 21.00 per share in cash at […]
Clinical Trials - March 18, 2024
Cantargia has reported new data highlighting the potential of the CAN10 antibody, currently in phase I clinical development, as therapy in systemic sclerosis. All signaling systems targeted by CAN10 (IL-1, IL-33 and IL-36) were found to be highly upregulated in patient skin biopsies. These cytokines induce fibrosis in skin fibroblasts isolated from patients, and this […]
Intellectual Property - March 18, 2024
The European Patent Office (EPO) has granted a further patent in Salipro Biotech’s patent portfolio: European Patent entitled “Production of Salipro particles”. This patent covers processes related to the Salipro platform and represents a pivotal milestone that strengthens Salipro Biotech’s position as a key drug discovery platform holder for difficult drug targets such as GPCRs, […]
Global report - March 15, 2024
The researchers are convicted of misconduct, according to a decision from the Board for Examination of Research Misconduct, NPOF. This is due to partially manipulated and falsified images in a scientific article, reports Läkartidningen. The five scientific articles are in the cancer area, and NPOF, after taking the help of an expert, has come to […]
In a new job - March 15, 2024
The board of directors at Boule Diagnostics has appointed Torben Nielsen as the new CEO and President, effective no later than June 14, 2024. Torben Nielsen will replace Jesper Söderqvist, who has been the CEO since 2020. Jesper will be available to the company during a transition period and will leave his position at latest […]
Business article - March 15, 2024
Following discussions with the board, the company’s founders Erik Gatenholm and Hector Martinez are leaving BICO. “I want to thank Erik and Hector for their efforts. Without them, the company would not have existed, let alone contributed to the change in the industry,” says Rolf Classon, Chairman of the Board. Erik Gatenholm and Hector Martinez […]
This site uses cookies